However, Rh2, by enhancing ROS, partially counteracts p53-induced apoptosis by activating AMPK and NF-κB signaling pathways to promote cancer survival and growth and can exert better anticancer effects when applied in combination with antioxidants (Li et al., 2011). Here, TP53 is linked to cancer.